{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:39Z","timestamp":1791225759583,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143552","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T21:41:19Z","timestamp":1448401279000},"page":"e0143552","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates"],"prefix":"10.1371","volume":"10","author":[{"given":"St\u00e9phane","family":"Leung-Theung-Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gouanvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Antoine","family":"Coupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Seegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Huaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Cristillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Inchausp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"ref1","unstructured":"WHO. Global tuberculosis report. WHO, Geneva, Switzerland. 2014."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"IM Orme","year":"2015","journal-title":"Nat Immunol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/ciu186","article-title":"The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study","volume":"58","author":"FM Marx","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref4","first-page":"10","article-title":"Exogenous reinfection of tuberculosis in a low-burden area","volume":"10","author":"C Schiroli","year":"2015","journal-title":"Infection"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.micpath.2012.12.002","article-title":"Vaccination against tuberculosis: how can we better BCG?","volume":"58","author":"JM Pitt","year":"2013","journal-title":"Microb Pathog"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2014a state of the art review","volume":"2","author":"SH Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines\u2014state of the art, and novel approaches to vaccine development","volume":"32","author":"C da Costa","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"205","key":"ref9","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"F Smaill","year":"2013","journal-title":"Sci Transl Med"},{"issue":"9871","key":"ref10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"issue":"20","key":"ref11","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"JT van Dissel","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"J Wang","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"53","key":"ref14","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"S Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/infdis\/jis425","article-title":"Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment","volume":"207","author":"RN Coler","year":"2013","journal-title":"J Infect Dis"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/CVI.00006-10","article-title":"Highly persistent and effective prime\/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant","volume":"17","author":"K Kolibab","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4161\/hv.21689","article-title":"Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines","volume":"8","author":"H Boukhebza","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"39","key":"ref18","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of Modified Vaccinia virus Ankara vaccines","volume":"31","author":"SC Gilbert","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JVI.54.1.30-37.1985","article-title":"In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals","volume":"54","author":"MA Cochran","year":"1985","journal-title":"J Virol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.60.2.436-449.1986","article-title":"Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment","volume":"60","author":"JL Rosel","year":"1986","journal-title":"J Virol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CVI.00678-13","article-title":"Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein","volume":"21","author":"C Remy-Ziller","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cyto.a.22008","article-title":"OMIP-005: Quality and phenotype of antigen-responsive rhesus macaque T cells","volume":"81","author":"KE Foulds","year":"2012","journal-title":"Cytometry A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jmv.20189","article-title":"Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen","volume":"ed2004","author":"P Martin","year":"2004","journal-title":"J Med Virol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2006.05.012","article-title":"Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime\/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses","volume":"353","author":"NV Malkevitch","year":"2006","journal-title":"Virology"},{"issue":"42","key":"ref25","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1016\/j.vaccine.2007.08.020","article-title":"An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses","volume":"25","author":"A Fournillier","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"S Bertholet","year":"2008","journal-title":"J Immunol"},{"issue":"41","key":"ref27","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2013.07.032","article-title":"Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens","volume":"31","author":"SC Derrick","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection","volume":"4","author":"SD Schuck","year":"2009","journal-title":"PLoS One"},{"issue":"Pt 9","key":"ref29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1099\/mic.0.037622-0","article-title":"Comparative expression analysis of rpf-like genes of Mycobacterium tuberculosis H37Rv under different physiological stress and growth conditions","volume":"156","author":"RK Gupta","year":"2010","journal-title":"Microbiology"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1128\/IAI.01735-07","article-title":"A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes","volume":"76","author":"E Russell-Goldman","year":"2008","journal-title":"Infect Immun"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"AM Cooper","year":"1993","journal-title":"J Exp Med"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"SV Capuano 3rd","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm0496-430","article-title":"The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease","volume":"2","author":"GP Walsh","year":"1996","journal-title":"Nat Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"PL Lin","year":"2012","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"ref35","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/313885","article-title":"A nonhuman primate model for preclinical testing of new tuberculosis vaccines","volume":"30","author":"DN McMurray","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"FA Verreck","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"CE Barry 3rd","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"T Lindenstrom","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity","volume":"26","author":"JS Woodworth","year":"2006","journal-title":"Crit Rev Immunol"},{"issue":"5386","key":"ref40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"S Stenger","year":"1998","journal-title":"Science"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.4049\/jimmunol.181.12.8595","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo","volume":"181","author":"JS Woodworth","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2014.11.013","article-title":"BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4(+)IL-17(+)TNF(+)IL-2(+) T cells","volume":"33","author":"A Cruz","year":"2015","journal-title":"Vaccine"},{"issue":"47","key":"ref43","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/j.vaccine.2014.09.024","article-title":"HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis","volume":"32","author":"C Verwaerde","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1128\/IAI.01392-09","article-title":"Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon","volume":"78","author":"TM Wozniak","year":"2010","journal-title":"Infect Immun"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MMBR.00021-14","article-title":"Tuberculosis vaccines and prevention of infection","volume":"78","author":"TR Hawn","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.1102696","article-title":"The importance of adjuvant formulation in the development of a tuberculosis vaccine","volume":"188","author":"SL Baldwin","year":"2012","journal-title":"J Immunol"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/CVI.00372-14","article-title":"The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative","volume":"21","author":"SL Baldwin","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"I Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"e115161","DOI":"10.1371\/journal.pone.0115161","article-title":"A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS","volume":"9","author":"E de Barra","year":"2014","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T20:11:22Z","timestamp":1599855082000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143552"}},"subtitle":[],"editor":[{"given":"Angelo A.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143552","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}